Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders

Digestive Diseases

Volumn 36, Issue 1, 2017, Pages 56-65

  Lopetuso, Loris Riccardo ^a,b   Petito, Valentina ^a   Graziani, Cristina ^a   Schiavoni, Elisa ^a   Paroni Sterbini, Francesco ^a   Poscia, Andrea ^a   Gaetani, Eleonora ^a   Franceschi, Francesco ^a   Cammarota, Giovanni ^a   Sanguinetti, Maurizio ^a   Masucci, Luca ^a   Scaldaferri, Franco ^a   Gasbarrini, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; Diverticular disease; Gut Microbiota; Irritable bowel syndrome; Ulcerative colitis

Indexed keywords

16S RRNA GENE; ADULT; AMPLICON; ARTICLE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DIVERTICULOSIS; DNA ISOLATION; DNA PURIFICATION; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FEMALE; GENE; GENE AMPLIFICATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; METAGENOMICS; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; ULCERATIVE COLITIS; HEALTH; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYLOGENY; PRINCIPAL COMPONENT ANALYSIS; SPECIES DIFFERENCE;

BIOLOGICAL MARKER;

ADULT; BIOMARKERS; DIVERTICULAR DISEASES; FEMALE; GASTROINTESTINAL MICROBIOME; HEALTH; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PHYLOGENY; PRINCIPAL COMPONENT ANALYSIS; SPECIES SPECIFICITY;

EID: 85021950300     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000477205     Document Type: Article

References (32)

1. Scaldaferri F, et al: The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol 2012; 46(suppl):S12-S17.
2. Walker WA, et al: Intestinal uptake of macromolecules. III. Studies on the mechanism by which immunization interferes with antigen uptake. J Immunol 1975; 115: 854-861.
3. Walker WA, et al: Intestinal uptake of macromolecules. IV.-The effect of pancreatic duct ligation on the breakdown of antigen and antigen-antibody complexes on the intestinal surface. Gastroenterology 1975; 69: 1223-1229.
4. Leser TD, Molbak L: Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environ Microbiol 2009; 11: 2194-2206.
5. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80.
6. Eckburg PB, et al: Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
7. Gill SR, et al: Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
8. Scanlan PD, Marchesi JR: Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and-independent analysis of faeces. ISME J 2008; 2: 1183-1193.
9. Backhed F, et al: Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920.
10. McCracken VJ, Lorenz RG: The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001; 3: 1-11.
11. Lievin-Le Moal V, Servin AL: The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 2006; 19: 315-337.
12. Manson JM, Rauch M, Gilmore MS: The commensal microbiology of the gastrointestinal tract. Adv Exp Med Biol 2008; 635: 15-28.
13. Parashar UD, et al: Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12: 304-306.
14. Daniels L, Philipszoon LE, Boermeester MA: A hypothesis: important role for gut microbiota in the etiopathogenesis of diverticular disease. Dis Colon Rectum 2014; 57: 539-543.
15. Chang C, Lin H: Dysbiosis in gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2016; 30: 3-15.
16. Choung RS, Locke GR 3rd: Epidemiology of IBS. Gastroenterol Clin North Am 2011; 40: 1-10.
17. Mayer EA, Savidge T, Shulman RJ: Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 2014; 146: 1500-1512.
18. Strate LL, et al: Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol 2012; 107: 1486-1493.
19. Cenit MC, et al: Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochim Biophys Acta 2014; 1842: 1981-1992.
20. Hold GL, et al: Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 2002; 39: 33-39.
21. Ley RE, et al: Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102: 11070-11075.
22. Ley RE, Peterson DA, Gordon JI: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837-848.
23. Frank DN, et al: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104: 13780-13785.
24. Rajilic-Stojanovic M, Smidt H, de Vos WM: Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007; 9: 2125-2136.
25. Tap J, et al: Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11: 2574-2584.
26. Lepage P, et al: Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011; 141: 227-236.
27. Gevers D, et al: The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15: 382-392.
28. Martinez-Medina M, et al: Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis 2009; 15: 872-882.
29. Berry D, Reinisch W: Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol 2013; 27: 47-58.
30. Lopetuso LR, et al: Gut microbiota: a key modulator of intestinal healing in inflammatory bowel disease. Dig Dis 2016; 34: 202-209.
31. Sokol H, et al: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105: 16731-16736.
32. Lopetuso LR, et al: Gut virome and inflammatory bowel disease. Inflamm Bowel Dis 2016; 22: 1708-1712.